Results 371 to 376 of about 398,963 (376)

Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

European Journal of Heart Failure, 2019
Milton Packer, Javed Butler, Gerasimos Filippatos   +2 more
exaly  

Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid‐range ejection fraction

European Journal of Heart Failure, 2019
Aldo P Maggioni, Alice Bonomi, Andrea Di Lenarda   +2 more
exaly  

Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry

European Journal of Heart Failure, 2018
Gianluigi Savarese, Juan Jesus Carrero, Bertram Pitt   +2 more
exaly  

Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta‐analysis†

European Journal of Heart Failure, 2012
Gillian Whalley, Marco Guazzi, Michel Komajda   +2 more
exaly  

Aiming at a Curative Strategy for Follicular Lymphoma

Ca-A Cancer Journal for Clinicians, 2008
exaly  

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019

Ca-A Cancer Journal for Clinicians
Farhad Islami, Marjorie L Mccullough
exaly